Milk sialoglycoconjugates can protect the gastrointestinal tract of the suckling neonate by competitively binding to invading pathogens and promoting growth of beneficial flora, and their potential role in postnatal brain development is of particular interest in human infant nutrition. Although the concentration and the distribution of sialoglycoconjugates have been extensively studied in the milk of various species, the investigation of sialyltransferase gene expression in the mammary gland, in the context of lactation, has been limited. The sialyltransferase enzyme ST6Gal I transfers sialic acid from CMP-sialic acid to type 2 (Galβ1,4GlcNAc) free disaccharides or the termini of N-or O-linked oligosaccharides using an α2,6-linkage. Expression of the ST6Gal I gene is primarily regulated at the level of transcription through the use of several cell and development-specific promoters, producing transcripts with divergent 5′ untranslated regions (UTR). In the mouse mammary gland, the novel 5′UTR exon (L) appears to be associated with a drastic increase in ST6Gal I gene expression during lactation. We find that rats also possess an exon (L), suggesting conservation of this regulatory mechanism in rodents. In contrast, an exon (L)-containing transcript was not detected in the lactating bovine or human mammary gland. We also observed a trend of increasing ST6Gal I gene expression in the bovine mammary gland, culminating in involution. This is in contrast to species such as mice where the greatest change in ST6Gal I gene expression occurs between pregnancy and lactation, suggesting different roles in rodents vs. other mammals for α2,6-sialylated oligosaccharides present in milk.
Introduction
Sialoglycoconjugates are integral to various, ubiquitous biological phenomena, such as cell-cell interaction, cell migration, adhesion and metastasis (Varki 1993; Hanasaki et al. 1995; Dall'Olio 2000; Varki 2007 ). Interestingly, they may have been co-opted by the mammary gland to fulfill a different role. Sialoglycoconjugates found in milk can protect the gastrointestinal tract of the suckling neonate by competitively binding to invading pathogens and promoting growth of beneficial flora (Coppa et al. 1990; Mouricout et al. 1990; McVeagh and Miller 1997; Wang et al. 2001; Martin-Sosa et al. 2003) , and their potential role in postnatal brain development is of particular interest in human infant nutrition (McVeagh and Miller 1997; Wang and Brand-Miller 2003) . Although the concentration and the distribution of sialoglycoconjugates have been extensively studied in the milk of various species, the investigation of sialyltransferase gene expression in the mammary gland during lactation has been limited.
The sialyltransferase enzyme ST6Gal I transfers sialic acid from CMP-sialic acid to either type 2 (Galβ1,4GlcNAc) free disaccharides or the N-acetyllactosamine termini of Nor O-linked oligosaccharides via an α2,6-linkage (Harduin-Lepers et al. 2001 ). ST6Gal I is expressed in a variety of cell types and tissues (Aasheim et al. 1993; Wang et al. 1993; Mercier et al. 1999; Dalziel et al. 2001) , with particularly high levels of expression observed in the liver (Dalziel et al. 1999; Dalziel et al. 2001) . The enzyme has been successfully purified from rat, chicken and human liver and rat hepatoma cells (Bendiak and Cook 1982; Miyagi and Tsuiki 1982; Sticher et al. 1991; Weinstein et al. 1982a Weinstein et al. , 1982b . A soluble form of ST6Gal I was also purified from bovine colostrum (Paulson et al. 1977) and was established to be the product of proteolytic cleavage of the Golgi membranebound enzyme. Mercier et al. (1999) identified and extensively characterized the bovine ST6Gal I gene, which has a coding region of 1218 nucleotides. The coding sequence consists of five exons, the last of which contains a 3′UTR of 2.7 kb. Four additional exons were identified in the 5′UTR, resulting in a total of nine exons spanning up to 80 kb of genomic DNA. The gene comprises a single open reading frame encoding a protein of 405 residues with a theoretical molecular weight of 46,250 Da. Structural feature predictions indicate that the enzyme is likely to have a type II membrane topology, which is typical of Golgi glycosyltransferases. The bovine ST6Gal I protein sequence exhibits a higher homology with the human enzyme than with the rat, mouse or chicken enzymes (Mercier et al. 1999) .
The human ST6Gal I gene shares similarities with its bovine ortholog. It is located on human chromosome 3 and also encodes a 405 residue protein across five exons, which span in excess of 40 kb of genomic DNA. Four additional exons have been discovered in the 5′UTR (Wang et al. 1993) .
Transcriptional regulation of the ST6Gal I gene is coordinated by the use of several cell-specific promoters that produce transcripts with divergent 5′UTR (Svensson et al. 1990; Wang et al. 1990; Wen et al. 1992) . The rat ST6Gal I gene, which has been extensively studied, is known to span over 80 kb and has a complex network of at least four promoters that regulate its expression (Wen et al. 1992) .
In vivo, three main families of bovine ST6Gal I transcripts have been characterized, leading to speculation of the existence of at least three separate promoters regulating the expression of the gene. Despite organization of the bovine gene being similar to both human (Wang et al. 1993 ) and rat (Svensson et al. 1990; Wang et al. 1990; Wen et al. 1992) , there are differences in the tissue distribution of its transcripts (Mercier et al. 1999) .
The existence of a novel, lactogenic ST6Gal I promoter was proposed by the authors of a study examining the dramatic induction of ST6Gal I mRNA in the lactating mammary gland of mice. The predominant ST6Gal I mRNA species expressed in the lactating mouse mammary gland is a novel isoform containing a unique untranslated exon derived from the ST6Gal I 5′UTR, dubbed exon (L). Exon (L) is 203 bp long and is located >48 kb 5′ of exon (I). Virgin mammary tissue exclusively expressed the housekeeping ST6Gal I mRNA form and probes specific to exon (L) confirmed that the exon (L)-containing transcript was only present in the lactating mammary gland and not in other tissues that were investigated (Dalziel et al. 2001) .
The mouse ST6Gal I gene is known to contain at least eight 5′UTR exons in addition to exons (I)-(VI) (Dalziel et al. 1999 (Dalziel et al. , 2001 Wuensch et al. 2000) . Several studies have demonstrated that, despite not being translated, ST6Gal I 5′ UTR exons exhibit a degree of nucleotide sequence conservation between species, with exons (I)-(VI) typically being well conserved (Aasheim et al. 1993; Wang et al. 1993; Mercier et al. 1999) .
As an initial step toward unraveling the pattern of the expression of sialyltransferase genes in the lactating mammary gland, we have investigated the conservation of the 5′UTR of the ST6Gal I gene between several mammalian species. In addition, using a 5′ rapid amplification of cDNA ends (5′RACE) approach, we demonstrate that an equivalent to the mouse ST6Gal I exon (L) is not expressed in the lactating bovine or the human mammary gland. Furthermore, expression of the bovine ST6Gal I gene is shown to be significantly increased at the onset of involution.
Results

Conservation analysis of the ST6Gal I gene
To investigate the level of conservation of 5′UTR exons characterized in the mouse and other mammalian species ( Figure 1A ; Wen et al. 1992; Wang et al. 1993; Mercier et al. 1999; Wuensch et al. 2000; Dalziel et al. 2001) , we compared mouse, human, bovine and rat ST6Gal I genomic sequence, including 100 kb of 5′UTR sequence, using the Vista suite of tools for comparative genomics (Frazer et al. 2004) . Figure 1B shows the Vista conservation plot calculated from pairwise genomic sequence alignments of the mouse ST6Gal I sequence with the other mammalian species. Translated exons (II)-(VI) are at least 75% conserved at the nucleotide sequence level for all pairwise comparisons, with the greatest degree of conservation seen between the mouse and the rat sequences. Ubiquitously present 5′UTR exon (I) is also conserved by at least 75% for all sequence comparisons.
As expected, all mouse 5′UTR exons are highly conserved in the rat at the nucleotide sequence level, except 5′UTR exon (X1 b ), which does not appear to be present in the rat sequence. Mouse exon (O) is particularly well conserved across all species; more than 75% identity is observed with human and rat and just under 70% with bovine. A multiple sequence alignment of mouse exon (O), rat exon (0), human exon (Z) and cow exon (0) sequences supports the Vista finding ( Figure 2B) .
Our Vista analysis also shows a reasonable level of conservation in the region of mouse exon (Q), particularly between the mouse and the rat. However, a direct alignment of the mouse exon (Q) and the rat exon (−1) (M83142) sequences showed only very poor sequence similarity (data not shown). The rat exon (−1) sequence was previously compared with the human exon (Y) by Wang et al. (1993) who noted that the sequence similarity was not dramatic. A comparable result was reported by Mercier et al. (1999) , where bovine exon (−1) was also included in the alignment. The Spidey (Wheelan et al. 2001 ) alignments of rat exon (−1), human exon (Y) and bovine exon (−1) to the mouse ST6Gal I genomic sequence revealed that human exon (Y) and bovine exon (−1) are derived from the ST6Gal I genomic region corresponding to mouse exon (Q) but that the rat exon (−1) sequence corresponds to an area of the mouse ST6Gal I genomic sequence that is actually the downstream of mouse exon (Q) and does not directly align with the mouse exon (Q) sequence (Figure 3 ). Mouse exon (Q) is homologous to human exon (Y) and bovine exon (−1) (Figure 2A) . Interestingly, mouse exon (H), which is exclusively expressed in the mouse liver (Hu et al. 1997; Dalziel et al. 1999) , is highly conserved in the rat genomic sequence, despite evidence that rat does not express this 5′UTR exon (Wang et al. 1990; Shah et al. 1992; Vertino-Bell et al. 1994) . There is also a very high level of sequence conservation between the mouse and the rat in the region of mouse exon (L) ( Figure 4A ), which is exclusively expressed in the lactating mouse mammary gland (Dalziel et al. 2001) . Mouse exon (L) appears to be only moderately conserved in the human ST6Gal I genomic sequence ( Figure 4C ) and even less so in the bovine ( Figure 4B ).
5′RACE of ST6Gal I transcripts in bovine and human mammary gland Murine ST6Gal I expression is radically increased in the mammary gland during lactation (Dalziel et al. 2001 ). To 100 kb 5′UTR. The mouse ST6Gal I genomic sequence was used as the base sequence for alignment with the human (H), cow (C) and rat (R) ST6Gal I sequence. The sequences were submitted via mVista and aligned using the LAGAN algorithm for the global multiple alignment of finished sequences, with the option for translated anchoring selected to improve the alignment of distant homologs. All sequences were repeat-masked using species-appropriate masking. The plot represents percent conservation between the aligned sequences at a given coordinate on the base sequence, which is calculated as a windowed-average identity score for the alignment (default parameters were used for calculation). The top (100%) and the bottom (50%) percentage bounds are shown to the right of every row. Regions of high conservation (>70%) are colored as follows: exons (dark blue), UTRs (light blue) or noncoding ( pink).
ST6Gal I gene expression in the mammary gland investigate whether this phenomenon occurs in other mammals, we devised a 5′RACE strategy to assess the nature of the ST6Gal I isoforms expressed in the mammary gland of cows and humans.
We prepared cDNA by reverse transcription of RNA from the lactating mammary tissue of a day 34 postpartum Holstein-Friesian cow using bST1-SP1, an antisense primer designed to anneal to a region in ST6Gal I exon (II) ( Figure 5A ). The 5′ ends of the synthesized cDNA were then amplified using a nested primer, bST1-SP2, which is complementary to a segment of exon (I). A further amplification was carried out with a second nested primer, bST1-SP3, which binds to a region of exon (I) further 5′ than bST1-SP2. The major product, visualized on an agarose gel by SYBR Safe staining, migrated at 250 bp ( Figure 6 ). RNA extracted from the mammary glands of a pregnant cow at 8 days preparturition and a cow 5 days into involution was subjected to the identical 5′RACE procedure. The polymerase chain reaction (PCR) products were once again found to migrate at 250 bp ( Figure 6 ). The products visible on the gel ( Figure 6 ) were subsequently excised, purified and cloned.
Ten clones, from each stage of lactation, containing the SP3-derived PCR products were randomly selected for sequencing. All clones were confirmed to represent genuine ST6Gal I sequence as substantiated by the presence of ST6Gal I exon (I) sequence. Although all the clones contained >200 bp of sequence upstream of exon (I), the sequence was not found to represent a homologous bovine form of murine exon (L) at any of the time points investigated. All the 5′ sequences, at every stage of lactation, were found to contain bovine ST6Gal I exons (−1) and (0), representing the (−1 + 0) transcript family that was previously characterized by Mercier et al. (1999) .
RNA was also reverse-transcribed from cells extracted from the milk of a lactating woman collected at 49 days following birth. Antisense primer HST-P4, complementary to a section of human ST6Gal I exon (II), was used for reverse transcription. Nested primer HST-P3, designed to anneal in exon (I), was used for the first PCR amplification and second nested primer HST-P5, which binds further 5′ in exon (I), for the final amplification ( Figure 5B ). The major products were visualized as previously described and found to migrate at 350, 320, 190 and 150 bp. All four of the products visible on the gel ( Figure 7 ) were cloned. Five clones representing each HST-P5-derived product were randomly selected for subsequent sequencing. As with Fig. 3 . Pairwise alignment of mouse and rat ST6Gal I genomic sequence in the vicinity of mouse 5′UTR exon (Q), generated by Vista's LAGAN algorithm. The mouse exon (Q) sequence is highlighted in purple. Using Spidey, the rat and bovine exon (−1) and human exon (Y) sequences were mapped to the alignment. The rat exon (−1) sequence is highlighted in orange. Bovine exon (−1) maps to the mouse sequence denoted by lowercase and human exon (Y) maps to the underlined mouse sequence.
ST6Gal I gene expression in the mammary gland the bovine sequences, none of the human 5′ segments were found to be homologous to murine exon (L). Furthermore, the two largest products contained human ST6Gal I exons (Y) and (Z). The smaller products were incomplete extensions of the same exon (Y + Z)-containing transcript.
ST6Gal I gene expression in the bovine mammary gland
The expression of the ST6Gal I gene in the bovine mammary gland was assessed during pregnancy, lactation and involution. Mammary gland samples, obtained by surgical biopsy from the four Holstein-Friesian cows, at each of the three time points, were used for gene expression analysis. The expression level of ST6Gal I mRNA was determined for each sample using a quantitative PCR (qPCR) approach. To allow for the amplification of all ST6Gal I transcript families of the ST6Gal I gene, primers bST6.E2F and bST6.E3R were designed to anneal to regions in exons (II) and (III), respectively ( Figure 5A ). Figure 8 shows the mean normalized expression of the ST6Gal I gene in the mammary glands of four cows at the three stages of lactation sampled. Our analysis revealed a trend of increasing ST6Gal I gene expression in the bovine mammary gland between pregnancy and lactation, and lactation and involution. A statistically significant difference in ST6Gal I gene expression (P < 0.05) was found between pregnancy and involution.
ST6Gal I gene expression in bovine tissues
The ST6Gal I gene has been shown to be more highly expressed in the mouse liver than other tissues (Dalziel et al. 2001 ). An examination of ST6Gal I gene expression in bovine tissues showed that the kidney expressed higher levels of ST6Gal I mRNA than the brain, heart, lung or spleen (Mercier et al. 1999) . We investigated the relative expression of the ST6Gal I gene in the bovine liver, lactating mammary gland, brain stem, hind brain, lymph node, rumen, abomasum and reticulum by qPCR. Tissues were harvested from a lactating dairy cow that was sacrificed at 34 days postpartum. The bST6.E2F and bST6.E3R primers ( Figure 5A ) were used to detect the overall expression of the ST6Gal I gene. To discriminate between the individual ST6Gal I transcript families, primers were designed to the unique 5′UTR exons of each bovine ST6Gal I isoform; for transcript family 1, bST6f1. E-2F in exon (−2) and bST6f1.E1R in exon (I), for transcript family 2, bST6f2.E-1F in exon (−1) and bST6f2.E0R in exon (0), and for transcript family 3, bST6f3.E1F in the extended portion of exon (I) and bST6f3.E2R in exon (II) ( Figure 5A ).
ST6Gal I gene expression was significantly higher in the liver than any other tissue examined ( Figure 9A ). The lymph node demonstrated the next highest level of expression, ST6Gal I gene expression in the mammary gland relative to the liver, followed by the lactating mammary gland. Only very low levels of ST6Gal I gene expression were observed in the other tissues analyzed.
Using specific primers to discriminate between the individual bovine ST6Gal I transcript families, we were able to detect all three isoforms in all the tissues examined. Relative to the other tissues assessed, the lymph node expressed the highest levels of transcript families 1 and 3 ( Figure 9B and D). Transcript family 2 was expressed at similar levels in the brain stem, hind brain and lymph node and at lower levels in the other tissues ( Figure 9C ). Transcript families 2 and 3 were the best represented isoforms in the lactating mammary gland ( Figure 9C and D) .
Transcription factor-binding site analysis As homologous bovine exon (−1 + 0)-containing and human exon (Y + Z)-containing transcripts were found to be the most well represented isoforms in the mammary gland of both species, we investigated potential similarities and differences in transcription factor-binding sites (TFBS) of the putative promoter regions upstream of exons (−1) and (Y). Also, as we are primarily interested in ST6Gal I gene expression in the mammary gland, we focused our in silico promoter analysis on lactation-related TFBS, and TFBS involved in the acutephase response (APR), which has been implicated in early mammary gland involution (Stein et al. 2004 ) and has been demonstrated to affect hepatic ST6Gal I expression (Jamieson 1992; Dalziel et al. 1999) .
In the TFBS analysis, 2 kb of cow and human genomic sequence upstream of, and including, exons (−1) and (Y) was used. A transcription start site (TSS) was predicted the upstream of both exon (−1) in the cow sequence and exon (Y) in the human sequence ( Figure 10 ). As shown in Figure 10 , several lactation-related and APR TFBS were predicted to be conserved in this region. Two putative STAT5 motifs were identified, one of which is within 30 bp of one of the three predicted Oct-1 sites. Two potential C/EBPβ sites were also identified, in addition to possible binding sites for Sp1 and AP1.
Both the cow and the human sequences contained a putative glucocorticoid receptor (GR) binding site; however, its position was not found to be conserved in the alignment. A GR-C/EBPβ composite element was identified in the cow sequence at −736 from the predicted TSS, but was not present in the human sequence. Conversely, the human sequence contained a potential Sp1-PU.1 composite element at −149 from the predicted TSS, which was not detected in the cow sequence.
Discussion
The sequence, structure and organization of the ST6Gal I gene have been well characterized in several mammals (Svensson et al. 1990; Wang et al. 1990; Wen et al. 1992; Wang et al. 1993; Mercier et al. 1999) , and although the coding region of the gene is highly conserved between mammals, there is remarkable divergence in the pattern of expression of the different transcript families in some species (Dall'Olio 2000) . Despite their close evolutionary relationship, there are documented differences between rat and mouse ST6Gal I gene expression that are inconsistent with observed sequence similarity. Our analysis demonstrates that mouse exon (H) is very highly conserved in the rat genomic sequence, despite evidence that it is not expressed in rat tissues (Wang et al. 1990; Shah et al. 1992; Vertino-Bell et al. 1994) . Furthermore, an ST6Gal I transcript resembling the isoform expressed by the rat liver has been observed in human HepG2 cells (Aasheim et al. 1993) , suggesting that the liver-specific promoter upstream of exon (H) in mice may have evolved following their divergence from rats. The transcription of an additional 5′ exon in mice may allow for increased translational efficiency of that particular transcript (Kozak 1991a (Kozak , 1991b .
We also report that, although their parent transcripts exhibit similar patterns of expression, rat exon (−1) and mouse exon (Q) are not direct homologs at the genomic sequence level. The published sequence for rat exon (−1) is transcribed from a region further 3′ of where mouse exon (Q), human exon (Y) and bovine exon (−1) align. This accounts for the observation by Wang et al. (1993) that although human exon (Z) and rat exon (0) were described as homologous, the sequence similarity between human exon (Y) and rat exon (−1) was not significant.
The concentration and the distribution of sialoglycoconjugates in milk have been extensively studied for a variety of mammals; however, little is known about the expression of sialyltransferase genes in the mammary gland during lactation. Dalziel et al. (2001) reported the dramatic induction of ST6Gal I gene expression in the mouse mammary gland during lactation. This was achieved by the recruitment of a previously undocumented 5′UTR exon, exon (L), presumably regulated by an otherwise silent, lactogenic promoter. Our conservation analysis of the ST6Gal I 5′UTR genomic sequence between the rat and the mouse reveals that exon (L) is very highly conserved in the rat sequence. This suggests that ST6Gal I gene expression in the rat mammary gland during lactation may also be selectively elevated via the transcription of an exon (L)-containing isoform. Such a mechanism would be consistent with the observations of Ip (1980) , who documented an increase in the specific activity of rat ST6Gal I in the mammary gland throughout lactation, followed by a rapid return to basal values at the onset of involution. We suggest that rats and mice have evolved a mechanism to selectively up-regulate ST6Gal I in the lactating mammary gland to cater for the demand of α2,6-sialylated structures that serve as a delivery system for exogenous sialic acid. Rats and mice are born relatively immature and it has been shown that in comparison to adult levels, the liver of rat and guinea pig neonates has a diminished capacity to synthesize sialic acid (Gal et al. 1997; Nakano et al. 2001) . Furthermore, Dickson and Messer (1978) demonstrated a significant positive correlation between intestinal sialidase activity of suckling rats and mice, and sialic acid content of milk at the corresponding stage of lactation. They proposed that the main function of intestinal sialidase in suckling mammals is to participate in the digestion of sialylated milk components, thereby providing an exogenous supply of sialic acid for the neonate.
On the basis of speculation by Dalziel et al. (2001) that ST6Gal I elevation in the lactating mouse mammary gland may be required to address the increased demand for the sialylation of type 2 disaccharides in milk, we investigated the presence of exon (L)-containing ST6Gal I transcripts in human and bovine mammary gland. Interestingly, an equivalent lactation-specific transcript was not detected in either species. During pregnancy, lactation and involution, we only Fig. 8 . Expression of ST6Gal I in the bovine mammary gland at three stages of lactation. Mammary gland samples were obtained from four different cows by surgical biopsy at three stages of lactation. Each cow was sampled during late pregnancy, 8-23 days prepartum; peak lactation, 34 days postpartum; and involution, 5 days postweaning. Despite the increasing trend, there is no statistically significant difference in ST6Gal I gene expression in the bovine mammary gland between pregnancy and lactation, and lactation and involution; however, ST6Gal I gene expression does increase significantly between pregnancy and involution (P < 0.05).
ST6Gal I gene expression in the mammary gland identified the (−1 + 0) transcript in the bovine mammary gland, which was previously described in the lung and spleen (Mercier et al. 1999) . At day 48 of lactation, the human mammary gland expressed the (Y + Z) isoform, which is thought to be the constitutively expressed transcript (Wang et al. 1993) . Despite the documented differences in tissue distribution, the bovine (−1 + 0) and human (Y + Z) transcripts are homologous (Mercier et al. 1999) , exhibiting a high degree of sequence conservation in the 5′UTR. Our comparative analysis of the putative promoter regions upstream of bovine exon (−1) and human exon (Y) revealed several potentially conserved TFBS that are lactation-related. However, we also identified differences that may contribute to disparate regulation of this ST6Gal I transcript between species. We propose that the difference in regulation of the ST6Gal I gene in the lactating mammary gland observed between mice, humans and cows may be related to the unique nutritional and immune requirements of the neonate of each species. Furthermore, we suggest that differences in regulation between species are likely influenced by variation in the suite of TFBS present in the proximal promoter.
Our quantitative analysis of ST6Gal I gene expression in the mammary gland throughout the bovine lactation cycle revealed that ST6Gal I gene expression significantly increases by early involution. Involution of the bovine mammary gland occurs at a slower rate than in other mammals such as rodents (Capuco and Akers 1999) . After weaning, epithelial cells in the rat and mouse mammary gland rapidly undergo apoptosis, completely removing all alveoli within 2 weeks (Walker et al. 1989) . This is the first step in remodeling the mammary gland to a morphology closely resembling the tissue present in the mature virgin animal. Atabai et al. (2007) noted that, particularly during rapid forced weaning, mastitis is not a significant concern in rodents. In contrast, in ruminants such as the cow, active involution may take between 20 and 30 days (Holst et al. 1987) . The bovine mammary gland is particularly susceptible to infection during early involution as large volumes of milk continue to accumulate in the gland for up to 4 days after weaning, creating an excellent growth medium for bacteria (O'Toole 1995). The innate immune system plays an integral role in the defense of the mammary gland from infection at this stage (Sordillo et al. 1997) . For example, lactoferrin, a bacteriostatic iron-binding protein, is known to dramatically increase in concentration in bovine mammary secretions throughout involution (Rejman et al. 1989) . We propose that an increase in ST6Gal I gene expression in the involuting bovine mammary gland may reflect an increased requirement for α2,6-sialylated structures to contribute to local innate immunity. Laporte et al. (2009) have demonstrated that, in a primary culture of mammary epithelial cells, bovine ST6Gal II expression increases in response to IL-6, which is known to be expressed during mastitis.
A role for milk sialoglycoconjugates in the innate immunity of the neonate has previously been suggested (Martin et al. 2001; Wang et al. 2001; Martin-Sosa et al. 2003; Wang and Brand-Miller 2003) . The presence of α2,3-linked sialic acid on the host cell surface is known to be essential for the successful infection of some pathogens (Karlsson 1995) , and it has been proposed that elevated levels of the α2,6-linkage may contribute to innate immunity by acting as "decoys" for invading pathogens (Gagneux and Varki 1999) . It is conceivable, however speculative, that a similar mechanism may operate in the involuting bovine mammary gland during the period of milk stasis.
Increased expression of the ST6Gal I gene at the onset of bovine mammary gland involution may be driven by the expression of APR genes during the same period. As a result of their gene expression study of murine lactation, Stein et al. (2004) suggested a major role for the APR in the early stage of mouse mammary gland involution. The APR is a component of the innate immune system that provides an initial mechanism of defense against disease by minimizing tissue damage while promoting repair processes (Eckersall 2000) . Injury or infection usually stimulates acute-phase protein expression in the liver by the release of cytokines (Dinarello 1984; Beutler 1986 ). Jamieson (1992) showed that elevation of the liver and serum ST6Gal I is one component of the hepatic APR. Dalziel et al. (1999) went on to show that in mice, transcription of a novel ST6Gal I mRNA isoform containing 5′UTR exon (H) was responsible for the acutephase induction of hepatic ST6Gal I. Our analysis of the putative promoter region upstream of bovine ST6Gal I exon (−1) revealed the presence of a potential APR composite element, GR-C/EPBβ, which may account for the increased expression of ST6Gal I observed at the onset of involution. This combination of GR and C/EPB motifs in close proximity has been shown to be necessary for the maximal induction of the APR-reactant AGP gene (Klein et al. 1988; Williams et al. 1991; Ratajczak et al. 1992) . Furthermore, Nishio et al. (1993) demonstrated that NF-IL6, a member of the C/EPB family (Akira et al. 1990) , can directly interact with the GR and thus proposed that this interaction may be responsible for the synergistic activation of the rat AGP gene.
On the basis of our findings, we concur with previous suggestions that an exogenous supply of sialic acid may be necessary for the optimal development of mammalian neonates (Wang and Brand-Miller 2003) , however, as Dickson and Messer (1978) proposed, we argue that the use of exogenous sialic acid may be limited to species that give birth to relatively immature young that initially have a diminished capacity for sialic acid synthesis (Gal et al. 1997; Nakano et al. 2001 ). As such, it would be particularly interesting to investigate the expression of various sialyltransferases in the mammary gland of monotremes and marsupials, whose young are born in an extremely immature state and whose milk contains significant quantities of sialic acid (Messer and Kerry 1973) . Although we suggest that mammals which give birth to relatively well developed young may no longer have the Fig. 10 . Cross-species comparison of the putative ST6Gal I promoter region upstream of human exon (Y) and cow exon (−1). AVista conservation profile illustrates the level of similarity between human and cow sequences in the relevant region. A 2 kb human ST6Gal I genomic sequence upstream of exon (Y) was used for the alignment against a 2 kb cow sequence upstream of exon (−1). The top (100%) and the bottom (50%) conservation percentage bounds are shown on the right of the plot. Highly conserved (>70%) noncoding sequence is shown in pink, human untranslated exon (Y) is shown in blue. Aligned underneath the conservation profile is a schematic representation of the TFBSs identified in silico as potentially conserved between the two species or found to be present only in the cow, or only in the human sequence. TFBSs specifically relating to lactation or the APR were targeted. Potentially conserved TFBS positions were identified by rVista. Match (Biobase) was used to search for TFBSs in each sequence individually. MatrixCatch was utilized to locate potential composite elements in the human and the cow sequences. The composite elements identified are circled and their sequence is shown. The sequences corresponding to the positional weight matrix for each constituent TFBS are depicted in upper case, whereas the gap sequence is in lower case.
ST6Gal I gene expression in the mammary gland need for direct utilization of exogenously derived sialic acid, sialoglycoconjugates may still have a role in the innate immunity of the neonate, particularly in species such as humans where sialoglycoconjugates are a significant milk component. Additionally, we suggest that our observation of increasing ST6Gal I gene expression in the involuting mammary gland may indicate a role for α2,6-linked sialic acid during bovine mammary gland involution.
Materials and methods
Conservation analysis
Mouse, bovine and human genomic ST6Gal I sequences, with at least an additional 100 kb of 5′UTR, were obtained from Ensembl. The rat ST6Gal I genomic sequence was obtained from the Celera assembly of the Rattus norvegicus genome available through NCBI. Orthology of the sequences was confirmed using reciprocal best alignments and the examination of chromosomal context via the Ensembl and UCSC genome browsers. The annotation of the mouse ST6Gal I gene was acquired from Ensembl in the Vista format. Additional mouse 5′UTR exons were annotated by retrieving the sequences from GenBank: AF153680 (Q), AF153682 (X 2 ), U67989 (H), AF153684 (X 1a and X 1b ) and AF153683 (X 3 ); and aligning them to the 5′UTR of the mouse genomic ST6Gal I sequence using the Spidey mRNA-to-genomic sequence alignment program.
Conservation analysis of the mouse, bovine, human and rat ST6Gal I sequences was performed using the Vista suite of tools for comparative genomics (Dubchak et al. 2000; Frazer et al. 2004) . The sequences and annotations were submitted for analysis via the mVista interface. The LAGAN algorithm (Brudno et al. 2003) for the global multiple alignment of finished sequences was selected along with the option for translated anchoring to improve the alignment of distant homologs. All sequences were repeat-masked using species-appropriate masking. The resulting Vista plot was visualized using the Vista Browser with default parameters.
Collection of bovine mammary gland tissue and RNA extraction The collection of the bovine mammary gland tissue used in this study was previously described in Sheehy et al. (2004) . Briefly, the mammary gland tissue was collected from several Holstein-Friesian cows by surgical biopsy. Each cow was sampled during late pregnancy, 8-23 days prepartum; peak lactation, 34 days postpartum; and involution, 5 days postweaning. Mammary gland tissue from four different cows, at all three time-points, was used in this analysis.
Total RNA was isolated from 100 mg of each of the 12 bovine mammary gland tissue samples using the RNeasy Lipid Tissue Mini Kit from Qiagen. The RNA samples were quantified using the Biolab NanoDrop and checked for integrity on agarose gels.
Collection of human milk samples and RNA extraction Human milk was collected from a lactating female at 49 days following birth. Milk samples were centrifuged at 2000 g, 5 min at 4°C to pellet cells and milk was removed. Milk cells were resuspended in buffer 1 of the Qiagen RNeasy Micro Kit (Sydney, Australia) following the manufacturer's instructions for isolation of purified total RNA.
Collection of bovine tissues and RNA extraction A panel of tissues was collected from a lactating dairy cow that was slaughtered 34 days following birth. Total RNA was isolated from liver, abomasum, reticulum, rumen, brain stem, hind brain, lymph node and mammary gland tissue samples using the RNeasy Lipid Tissue Mini Kit from Qiagen as per the manufacturer's instructions.
5′-Rapid amplification of cDNA ends 5′RACE analysis was performed using the Roche Applied Science 5′/3′ RACE Kit (Sydney, Australia), second generation, as per the manufacturer's instructions. Briefly, 2 µg of bovine mammary gland total RNA was annealed to the primer bST1-SP1 (5′-TAATT CCCTTTCTTCTTTTCTTTCC-3′) and reverse transcribed. bST1-SP1 was designed to anneal to a region in exon (II), such that genuine reverse transcription events of ST6Gal I mRNA must span at least the exon (I)-(II) boundary. The resultant cDNA was purified using the High Pure PCR Product Purification Kit from Roche as per the instructions specified in the RACE Kit. A homopolymeric A-tail was subsequently added to the 3′ end of the purified cDNA. A first PCR amplification of the dA-tailed cDNA was then performed using the Promega (Sydney, Australia) GoTaq Green Master Mix with the ST6Gal I-specific primer bST1-SP2 (5′-GATGTCTGTTTTACTGGGTCTGG-3′) and the Oligo(dT)-anchor primer provided with the RACE Kit. The PCR was carried out in an MJ Research PTC-225 Pertier Thermal-Cycler at 94°C for 2 min, followed by 10 cycles at 94°C for 15 s, 55°C for 30 s and 72°C for 40 s, then another 25 cycles at 94°C for 15 s, 55°C for 30 s and 72°C for 40 s with an additional 20 s of extension after each cycle, and finally 72°C for 7 min. A second PCR was then performed using the GoTaq Green Master Mix with the ST6Gal I-specific nested primer bST1-SP3 (5′-CCAAGGCTCATTC TTCTCAG G-3′) and the PCR anchor primer provided with the RACE Kit. The PCR parameters were 94°C for 2 min, followed by 10 cycles at 94°C for 15 s, 60°C for 30 s and 72°C for 40 s, then another 25 cycles at 94°C for 15 s, 60°C for 30 s and 72°C for 40 s with an additional 20 s of extension after each cycle, and finally 72°C for 7 min.
5′RACE was also performed on 2 µg of human mammary gland total RNA as described previously. Human ST6Gal I primers reported by Wang et al. (1993) were used in the analysis; HST-P4 (5′-AACTTGATGCCTGGTCC-3′) was used for reverse transcription, HST-P3 (5′-CTCTGGTTTGGCCT TGG-3′) for the first PCR amplification and the nested primer HST-P5 (5′-CTGCTTCTGGCTAATC-3′) for the second PCR amplification. The cycling conditions for the first PCR amplification were: 94°C for 2 min, then 10 cycles at 94°C for 15 s, 55°C for 30 s and 72°C for 40 s, followed by another 25 cycles at 94°C for 15 s, 55°C for 30 s and 72°C for 40 s with an additional 20 s of extension after each cycle, and finally 72°C for 7 min. The second PCR amplification was carried out at 94°C for 2 min, 10 cycles at 94°C for 15 s, 50°C for 30 s and 72°C for 40 s, followed by another 25 cycles at 94°C for 15 s, 50°C for 30 s and 72°C for 40 s with an additional 20 s of extension after each cycle and finally 72°C for 7 min.
All products of the 5′RACE second PCR amplification were separated by electrophoresis on 2% agarose gels and the major bands subsequently excised and purified using the Qiagen QIAquick Gel Extraction Kit. The purified PCR products were then cloned into the plasmid vector pGEM-T Easy (Promega) and sequenced.
Quantitative PCR cDNA was generated from 2 µg of total RNA using the Invitrogen SuperScript VILO cDNA Synthesis Kit (Melbourne, Australia) as per the manufacturer's instructions. qPCR was performed according to the instructions for using the EXPRESS SYBR GreenER qPCR SuperMix with Premixed ROX supplied by Invitrogen. All qPCR primers were designed using Primer3 (Rozen and Skaletsky 2000) and checked for primer-dimer formation, self-annealing and hairpin formation using PerlPrimer (Marshall 2004) and OligoCalc (Kibbe 2007) . To detect overall ST6Gal I expression, a forward primer bST6.E2F was designed in bovine ST6Gal I exon (II) (5′-GGTGTGCTGTGGTCTCTTCA-3′) and a reverse primer in exon (III) bST6.E3R (5′-CCCACGTCTTGTTGGAATTT-3′). To distinguish the expression profiles of individual ST6Gal I transcript families, primers were designed to the unique 5′UTR exons of each bovine ST6Gal I isoform: for transcript family 1 bST6f1.E-2F (5′-GGGTCTGCTCCTGATACCAC-3′) in exon (−2) and bST6f1.E1R (5′-CAAGGCTCATTCTTCTCA GGA-3′) in exon (I), for transcript family 2 bST6f2.E-1F (5′-CACTAC CCGGTGCTAACAAA-3′) in exon (−1) and bST6f2.E0R (5′-GCAGATCTCAGCACAATTCACT-3′) in exon (0), and for transcript family 3 bST6f3.E1F (5′-GCAGA CTTGTCTTA GCTGATGG-3′) in the extended portion of exon (I) and bST6f3.E2R (5′-CAAGGAAACCACGCTGT TCT-3′) in exon (II). All primers were deliberately designed over intron-exon boundaries to facilitate detection of any genomic DNA contamination. Primers reported by Bionaz and Loor (2007) for ribosomal protein subunits RPS9 [RPS9.192F (5′-CCTCGACC AAGAGCTGAAG-3′), RPS9. 254R (5′-CCTCCAGACCT CACGTTTGTTC-3′)] and RPS15 [RPS15.405F (5′-GCA GCTTATGAGCAAGGTCGT-3′), RPS15.555R (5′-GCTCATC AGCAGATAGCGCTT-3′)] and ubiquitously expressed transcript UXT (UXT.323F (5′-TGT GGCCCTTGGATATG GTT-3′), UXT.423R (5′-GGTTGTCGC TGAGCTCTGTG-3′)] were used as internal controls. For all reactions, the final reaction mixture of 20 µL consisted of 200 nM forward primer, 200 nM reverse primer, 2 µL of 1 in 20 diluted cDNA and 10 µL of the 2× EXPRESS SYBR GreenER qPCR SuperMix with Premixed ROX. PCR parameters for the Eppendorf RealPlex MasterCycler epgradients were 50°C for 2 min, 95°C for 10 min, 40 cycles at 95°C for 15 s then 60°C for 1 min, followed by a melt-curve dissociation cycle at 95°C for 15 s then 60°C for 1 min and a 20 min ramp up to 95°C for 15 s. The raw Ct values were imported into Biogazelle's qBasePlus software for calculation of calibrated normalized relative quantities (CNRQs) and their standard errors. The CNRQs were used in subsequent statistical analysis.
Statistical analysis
Significant differences in ST6Gal I gene expression in the bovine mammary gland between the stages of lactation were determined using the paired t-tests, assuming unequal variances. For all analyses, a P-value of <0.05 was interpreted as statistically significant.
TFBS analysis
For all TFBS analyses, 2 kb of human ST6Gal I genomic sequence upstream of, and including, exon (Y) and 2 kb of bovine sequence upstream of, and including, exon (−1) were used. All TFBS searches were restricted to lactation and APR-related transcription factors. Potentially conserved TFBS positions were identified by rVista (Loots et al. 2002) , which makes TFBS predictions using the Match program based on TRANSFAC Professional 9.2, and determines which of the predicted sites are conserved between the species in the alignment. A core similarity value of 0.95 and matrix similarity value of 0.75 were used as cut off parameters for the TRANSFAC search. Match (Biobase) was used to search for TFBSs in each sequence individually, with default parameters for minimizing false positives. The MatrixCatch (Kel et al. 1999) program was used to locate potential composite elements in the human and cow sequences, also using its default parameters. This program uses a library of experimentally identified composite elements collected in the TRANSCOMPEL (Kel-Margoulis et al. 2002) database, as well as mononucleotide position weight matrices for individual TFBS collected in TRANSFAC. Transcription start sites were predicted using TSSG (Softberry).
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